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Poly-N-isopropylacrylamide (PNIP), a water-soluble,
thermally precipitated synthetic polymer, has been
conjugated together with a monoclonal antibody and
utilized as a novel separation method for an
immunoassay. PNIP precipitates out of water above a
critical temperature of 31 °C, enabling a polymer-bound
immune complex to be separated from the solution. These
characteristics were used to develop a novel
polymer–mimetic enzyme immunoassay method for
determination of a-1-fetoprotein (AFP) with hemin as a
labeling reagent to catalyze the reaction of
p-hydroxyphenyl acetic acid (HPA) and hydrogen
peroxide in alkaline medium. After a one-step competitive
immunoreaction, the polymer–antibody–antigen–hemin
conjugate moiety was determined by coupling the
fluorogenic reaction of HPA and hydrogen peroxide. The
calibration graph for AFP was linear over the range of
0–380 ng cm23 with a detection limit of 1.0 ng cm23. This
method combines some advantages of both homogeneous
and heterogeneous immunoassays, and has been applied
to determine AFP in human blood serum with satisfactory
results.
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Application of immunoassay techniques is now very wide-
spread playing an important role in a variety of fields, for
example, diagnostic medicine, forensics, drugs and diagnosis of
infectious diseases. Generally, immunoassays can be divided
into two categories, homogeneous and heterogeneous. Homo-
geneous immunoassays have the advantages of being rapid,
easy to perform, and readily amenable to automation. However,
the drawbacks of these methods such as poor sensitivity, and
being prone to interference, have limited their application. On
the other hand, heterogeneous assays are generally more
sensitive than homogeneous assays, less prone to interference,
and can be used for both low and high molecular weight
analytes. However, they tend to be time consuming and labor-
intensive because of the requirement of multiple wash steps.
The problems mentioned above for both homogeneous and
heterogeneous immunoassays can be solved by using certain
water-soluble polymers to carry out a fast homogeneous
immune reaction and a simple heterogeneous separation
process. The polymers are known to precipitate when the
temperature is raised above the lower critical solution tem-
perature (LCST) at which demixing occurs.1,2 Among the
polymers, poly-N-isopropylacrylamide (PNIP) is known to
have an LCST of about 31 °C throughout a wide concentration
range (up to ca. 5%). We have utilized this demixing behavior
of PNIP above the LCST as the separation  technique in our new
immunoassay.
Enzymes such as horseradish peroxidase (HRP) and alkaline
phosphatase (ALP) are the most common labels for enzyme
immunoassays. However, enzymes are relatively expensive and
their solutions are not very stable; in addition, enzyme labels
inevitably lead to steric hindrance against the immunoreaction
of antigen and antibody due to their large molecular weight.
Therefore, the study of small molecular mimetic enzymes as
catalysts for fluorogenic reactions has increased markedly in
recent years.3–6 Hemin, a natural low molecular weight Fe–
porphine complex, is an inexpensive product from bovine blood
and very stable in solution, and has been used as a catalyst in
chemiluminescence immunoassays.7,8 Recently, we reported
that hemin exhibited very significant catalytic activity for the
peroxidation reaction of thiamine and hydrogen peroxide,9 and
we developed a new sandwich mimetic enzyme immunoassay
for the hepatitis B surface antigen.10 A search of the Chemical
Abstracts database in November 1997 indicated that using
hemin as a labeling reagent in a competitive mimetic enzyme
fluorescence immunoassay had not previously been reported. In
the present work, hemin was used as a substitute for HRP to
label AFP antigen, and it was found that the conjugated hemin
retained high catalytic activity for the reaction between HPA
and hydrogen peroxide in alkaline media. Therefore, we
describe here a novel polymer–mimetic enzyme immunoassay
method. This method can be employed for sensitive detection of
AFP by a competitive immunoassay technique. The standard
AFP and AFP–hemin first reacted with PNIP–antibody (PNIP–
Ab), then the temperature of the solution was raised above the
polymer’s LCST to cause the polymer–immune complex to
precipitate, and the bound hemin-labeled antigen was quantified
by fluorescence measurement (Fig. 1). The use of PNIP as a
carrier and hemin as labeling reagent is expected to provide not
only a simple immunoassay procedure but also long-term
stability. In addition, since the polymer–immune complex may
be reversibly redissolved by cooling, the method may be used to
concentrate and isolate the analyte.
Experiment
Materials
Standard AFP and monoclonal mouse anti-AFP antibody were
obtained from Xiamen Advanced Scientific Inc. (Xiamen,
China). Water-soluble carbodiimine (EDC) and Sephadex G-50
were purchased from SABC (Shanghai, China). Bovine serum
albumin (BSA) was obtained from Shanghai Biochemicals
(Shanghai, China). All the chemical reagents were of analytical-
reagent grade. Hemin was obtained from Dongfen Biochemical
Reagent Co. (Shanghai, China). p-Hydroxyphenyl acetic acid
was purchased from TCI-EP (Tokyo Kasei, Japan). Hydrogen
peroxide (30%) was from Shanghai Taopu Chemical Factory
(Shanghai, China). N-Isopropylacrylamide (NIP), N-hydroxy-
succinimidyl acrylate (NAS) were synthesized  as de-
scribed.11,12 Ammonium persulfate and N,N,NA,NA-tetramethyl-
ethylenediamine (TEMED) were purchased from TCI-EP
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(Tokyo, Kasei) and used without further purification. Phosphate
buffered saline (PBS) solutions at pH 7.4 and 8.0 at a
concentration of 0.1 mol cm23 were used. Distilled, deionized
water was used throughout.
Instruments
A Hitachi 650-10S spectrofluorimeter (Tokyo, Japan) equipped
with a plotter unit and a 1 cm quartz cell was used for recording
and making fluorescence measurements. The absorption spec-
trum was performed on a Shimadzu UV-240 UV/VIS spec-
trophotometer (Kyoto, Japan). All the pH measurements were
made with a digital pH and temperature meter 631 (Extech,
Boston, USA). A TGL-16G supercentrifuge (Shanghai, China)




A 4 cm3 portion of PBS, pH 8.0, containing 200 mg of antibody
and 30 ml of 0.1% (m/v) NAS were mixed and vibrated in a 37
°C water bath for 60 min in order to form the monomer
conjugate, then the mixture was dialyzed three times against
PBS (pH 8.0) at 4 °C and concentrated to 2 cm3. The solution
was poured into 8 cm3 PBS (pH 7.4), and then 150 mg of NIP
was added to this solution. The polymerization was carried out
with 200 ml of 1% (m/v) ammonium persulfate and 10 ml of
TEMED at 25 °C for 2 h. After finishing the polymerization
reaction, the solution was centrifuged at 37 °C for 10 min
(10 000 rpm) to precipitate and separate the PNIP–Ab con-
jugate. The supernatant was removed, and the precipitate
dissolved in 10 cm3 of cold PBS, pH 7.4. The procedure was
repeated three times. Finally, the PNIP–Ab conjugate was
dissolved in 10 cm3 of cold PBS buffer solution, pH 7.4, and
stored at 210 °C.
Preparation and characteristics of hemin-labeled AFP
conjugate
Hemin was bound to AFP with EDC as a coupling agent. A
portion (15 mg) of hemin was dissolved in 1 cm3 of
dimethylsulfoxide, and 10 mg of the EDC was added. The
mixture was incubated for 30 min at 25 °C with magnetic
stirring. Then 2 cm3 of AFP solution (the AFP solution was
dialyzed three times against 1% (m/v) sodium chloride solution
at 4 °C and then concentrated to 2 cm3) was added. The mixture
was stirred for 3 h at 25 °C. The pH of the solution was
maintained at 5.0 ± 0.5 by the addition of 0.1 mol dm23 HCl and
NaOH during the coupling reaction. The mixture was centri-
fuged at 4 °C and the centrifugate was collected, then 5 cm3 of
0.1 mol dm23 phosphate buffer of pH 7.0 was added to the
precipitate, followed by centrifugation at 4 °C, to retrieve the
soluble product. All the centrifugates were mixed and saturated
by adding enough ammonium sulfate and then left at 4 °C
overnight. The precipitate was dialyzed three times against 0.1
mol dm23 phosphate buffer solution (pH 7.0) at 4 °C (each time
for 1 h against 1.0 l of phosphate buffer solution). The final
product, a pale brown solution, was concentrated and passed
through a 50 3 1.5 cm column packed with Sephadex G-50. The
eluent was 0.1 mol dm23 phosphate buffer solution (pH 7.0).
The conjugate gave a broad absorption band with a peak at
390 nm and a shoulder at 280 nm. The concentrations of AFP
and hemin were determined by the measurements of the
corresponding absorbance at 260, 280 and 390 nm based on the
assumption that the molar absorptivities of hemin at 260, 280
and 390 nm were 3.1 3 104, 3 3 104 and 9.3 3 104 dm3 mol21
cm21, respectively. The concentrations of hemin and AFP were
1.77 3 1025 mol dm23 and 9.04 3 1026 mol dm23,
respectively. The approximate molar ratio was 2.
Immunoassay for AFP
Standard AFP solution (50 ml) or patient serum sample (or 500
ml of normal human blood serum) and 25 ml of hemin-labeled
AFP (1 : 10 dilution) were added to the mixed solution of 50 ml
of PNIP–Ab and 350 ml of PBS, pH 7.4, containing 3% BSA and
0.1% Tween-20. The mixture was diluted to 1.0 cm3 with 0.1
mol dm23 PBS (pH 7.4) and vibrated for 10 min at 25 °C to
allow the specific binding to occur. The polymer was then
precipitated by incubating for 10 min at 37 °C. The resultant
precipitate was centrifuged at 10 000 rpm for 10 min at 37 °C,
the supernatant was withdrawn, and the precipitate redissolved
in 1 cm3 of ice-cold PBS (pH 7.4). This procedure was repeated
three times, and the precipitate finally gained was mixed with
500 ml of 0.01 mol dm23 NaOH, 300 ml of 6 3 1024 mol dm23
H2O2 and 200 ml of 0.01 mol dm23 HPA. The mixture was
allowed to stand at 25 °C for 15 min and the fluorescence
intensity was measured at 410 nm with excitation at 320 nm. A




HPA is an excellent fluorescent substrate for horseradish
peroxidase.13,14 Similarly, in the presence of conjugated hemin,
it can also be rapidly oxidized by hydrogen peroxide to produce
fluorescent bi-p, pA-hydroxyphenylacetic acid which shows an
excitation maximum at 320 nm and a fluorescence emission
maximum at 410 nm.Fig. 1 Protocol for the polymer–mimetic enzyme immunoassay method.




















































Optimization of catalytic reaction conditions
The fluorescence reaction catalyzed by the conjugated hemin
was studied. The results indicated that the maximum fluores-
cence intensity was reached when the HPA concentration was in
the range of 1.6 3 1023–4.0 3 1023 mol dm23. A HPA
concentration of 2.0 3 1023 mol dm23 is recommended.
Similarly, the fluorescence intensity was the highest and
constant when the concentration of H2O2 was varied from 1.2 3
1024 mol dm23 to 2.0 3 1024 mol dm23; when the H2O2
concentration exceeded 4.0 3 1024 mol dm23, the fluorescence
intensity was decreased remarkably. In this work, 1.8 3 1024
mol dm23 H2O2 is recommended for use.
The effect of pH on the catalytic reaction was examined; the
results showed that the fluorescence intensity dramatically
increased with the increased of pH. In this work, NaOH was
chosen to control the pH of the system, and the maximum
fluorescence occurred when the final concentration of NaOH
was in the range of 4.0 3 1023–8.0 3 1023 mol dm23.
Therefore, 5.0 3 1023 mol dm23 NaOH (final pH 11.7), is
recommended. The influence of temperature and reaction time
was also studied. The fluorescence intensity was constant over
the temperature range of 20–30 °C; 25 °C is recommended. The
fluorescence intensity of the system approximated to constant
after reacting for 13 min at 25 °C (Fig. 2). In this paper, a
reaction time of 15 min was chosen, and the equilibrium method
was used.
Catalytic activity of hemin–AFP conjugate
Conjugated hemin was assayed for its catalytic activity for the
reaction of HPA with hydrogen peroxide under the optimum
conditions described above. The results showed that hemin
retained its catalytic activity when it was covalently bound to
AFP, and there was good linearity between the fluorescence
intensity and the concentration of hemin–antigen conjugate in
the range of 0–600 ng cm23 AFP (higher concentrations were
not tested) (Fig. 3). Thus the conjugate can be quantified in this
concentration range. This indicated that hemin can be used as a
sensitive label in the immunoassay due to its excellent
amplification in the HPA–hydrogen peroxide system. Hemin–
AFP conjugate was reacted with PNIP–anti-AFP antibody in a
solution, and the catalytic activity in PNIP–antibody–antigen–
hemin form was tested. There was no noticeable difference in
catalytic activity between hemin–AFP and PNIP–antibody–
antigen–hemin conjugate.
Optimization of immunoassay conditions
The effect of the concentration of hemin-labeled AFP conjugate
was examined; the experiement results showed that the optimal
concentration for the conjugate was in the range of 0.63–1.89 mg
cm23. A hemin–AFP conjugate concentration of 1.62 mg cm23
(25 ml of 1 : 10 dilution of the original solution) is recom-
mended. The influence of the volume of PNIP–anti-AFP
solution was studied, and 50 ml of PNIP–anti-AFP in the system
was optimal.
Calibration graph for AFP
The calibration curve for the determination of AFP was
constructed under the optimal conditions aforementioned. A
good linear relationship was observed between the fluorescence
intensity and AFP concentration, and AFP can be determined in
the range of 0–380 ng cm23. The linear regression equation was
y = 22.2x + 915.2, with a correlation coefficient of 0.996 (n =
8), where x (AFP) is in ng cm23. The detection limit (3s) for
AFP was calculated from the standard deviation of the blank (n
= 6) as 1.0 ng cm23
Our thermally induced phase-separation immunoassay
method offers several advantages over conventional heteroge-
neous methods, such as second antibody precipitation, anti-
body-coated magnetic particles and antibody-coated test tubes,
etc. First, the specific binding reaction occurs in solution rather
than on a solid surface. Hence, the immune reaction is more
rapid, and the incubation time can be reduced significantly.
Second, nonspecific bonding is low. This is probably related to
the fact that the polymer used in our method is hydrophilic,
unlike typical solid-phase systems which utilize polystyrene or
other hydrophobic materials. Finally, since the polymer–
immune complex can be reversibly redissolved by cooling, the
signal (or analyte) may be concentrated.
Immunoassay of AFP in blood sera
The AFP levels in healthy human serum and colon carcinoma
patient serum were determined by the proposed assay. These
samples were also analyzed in an anti-epidemic station
laboratory by the conventional ELISA method. Results ob-
tained by these two methods are summarized in Table 1. TheFig. 2 Kinetic profile for the fluorescence development with the time.
Temperature, 25 °C; HPA, 2.0 3 1023 mol dm23; H2O2, 1.8 3 1024 mol
dm23; conjugated hemin, 1.8 3 1028 mol dm23.
Fig. 3 Catalytic activity of hemin–AFP conjugate. HPA, 2.0 3 1023 mol
dm23; H2O2, 1.8 3 1024 mol dm23; temperature, 25 °C; reaction time, 15
min.
Table 1 Determination of AFP in human serum
AFP levels
RSD Re-
This method*/ ELISA*†/ (n = 6) Added/ covery
Sample No. ng cm23 ng cm23 (%) ng (%)
Healthy serum
1 25.2 — 6.3 — —
2 28.9 — 6.7 — —
Patient serum
3 477 > 400 8.0 20 90
4 421 > 400 7.3 20 85
5 513 > 400 5.2 20 99
* Mean of six determinations. † ELISA assay for AFP detection was
performed with a commercial kit (Beijing North TZ-Biotech. Development
Co.), and the results of detection were supplied by Xiamen Municipal
Health and Anti-epidemic Station.




















































relative standard deviation within a batch was below 8% (n = 6)
for the determination of AFP in human blood serum. The
possibility of using the proposed method for the analysis of
samples was further confirmed by determining the recovery of
known amounts of AFP added to the sample. The results in
Table 1 show that the recoveries are satisfactory, and the
reproducibility of the determination is good.
Conclusion
By using PNIP to replace surface in ELISA, the immune
reaction can be carried out in the homogeneous phase because
of the solubility of PNIP in water, and the polymer–antibody–
antigen immune complex can be separated by precipitation and
centrifugation above 31 °C. Hemin–AFP conjugate shows a
high catalytic activity for the fluorescent reaction of HPA and
hydrogen peroxide. The use of hemin as a labelled catalyst leads
to a paticularly stable, inexpensive, simple and sensitive
immunoassay for AFP. The proposed method has been applied
to determine AFP in healthy and patient human blood serum
with satisfactory results.
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